This content is machine translated Current status of a nearly 70-year therapy Radioiodine therapy in differentiated thyroid carcinoma. For papillary and follicular thyroid carcinomas, ablative radioiodine therapy with TSH stimulation is given four to six weeks after surgery. Studies show that high standard activity (3.7 GBq vs. 1.1…
